Phase I Study of MLN 9708 in Addition to Chemotherapy for the Treatment of Acute Lymphoblastic Leukemia in Older Adults
Status: Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 24 May 2019
Price : $35 *
At a glance
- Drugs Ixazomib (Primary) ; Cyclophosphamide; Cytarabine; Doxorubicin; Mercaptopurine; Methotrexate; Prednisone; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 22 May 2019 Status changed from recruiting to active, no longer recruiting.
- 04 Dec 2018 Results assessing safety and efficacy presented at the 60th Annual Meeting and Exposition of the American Society of Hematology.
- 03 Apr 2018 Planned End Date changed from 1 Jul 2020 to 1 Jul 2021.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History